QuanDx's Series B Round

QuanDx raised a round of funding on March 14, 2014.

QuanDx is a molecular diagnostics pioneer developing technologies and products for a variety of clinical applications. The company develops and commercializes molecular diagnostic tests for personaliz…

Articles about QuanDx's Series B Round: